DEMOCRATIC REPUBLIC OF THE CONGO / RankWire.AI / – The African Development Bank Group has approved $13 million in emergency grants to strengthen efforts to contain a new outbreak of the Ebola virus disease in central and eastern Africa. The financial package is specifically designed to enhance national emergency responses and curb the spread of the virus in the Democratic Republic of the Congo (DRC), South Sudan, and Uganda. This rapid funding deployment aims to reinforce regional containment strategies and lower the mortality rate among populations in the highest risk zones.
The current health crisis originated in the DRC, where authorities officially announced the new outbreak on May 15, 2026. The epidemic initially centered in the eastern Ituri province, heavily affecting areas such as Bunia, Rwampara, and Mongwalu. Since its detection, the virus has rapidly expanded beyond its initial epicenter, spreading to the neighboring North Kivu and South Kivu provinces. Health experts have identified the cause as the Bundibugyo strain of the Ebola virus, a highly virulent variant for which there is currently no approved vaccine or specific medical treatment.
To ensure swift action, the comprehensive funding package is divided into two distinct grants managed by leading international health organizations. A primary grant of $10 million is being drawn from reallocated resources within the existing DRC portfolio of the African Development Bank. These core funds will be channeled directly through the World Health Organization. A secondary grant of $3 million, sourced from the bank’s Multi-Country Emergency Assistance Project covering the DRC, Uganda, and South Sudan, will be implemented by the Africa Centres for Disease Control and Prevention.
The financial allocations have been strategically distributed to address the varying levels of crisis severity across the affected nations. As the primary epicenter of the current epidemic, the DRC will receive the bulk of the support with an $11 million allocation. Uganda and South Sudan will each receive $1 million from the Multi-Country Emergency Assistance Project. These targeted disbursements are intended to bolster preventative measures, reinforce national health infrastructure, and prepare border regions for potential cross border transmission.
Operating under the institutional Ebola Virus Disease Outbreak Response Plan, the capital will be deployed in close coordination with the respective national health ministries. The operational focus centers on halting the spread of the virus while simultaneously reducing related mortality and morbidity in vulnerable areas. Critical components of the intervention include strengthening early case diagnosis capabilities and expanding active epidemiological surveillance networks. The funds will also support vital community engagement, public awareness campaigns, and extensive regional coordination to unify the medical response.
Mohamed Cherif, the Deputy Director General for Central Africa and the DRC country manager for the African Development Bank, emphasized the urgent necessity of the financial intervention. “This emergency support reflects the African Development Bank Group’s commitment to supporting the Democratic Republic of Congo and countries in the region in protecting human lives, strengthening the resilience of health systems and preventing the spread of the epidemic,” Cherif stated. He further noted that the institution reaffirms its pledge to stand by its regional member countries during periods of profound crisis.
The international healthcare community remains on high alert as the situation develops. Because pharmacological interventions are not an option for the Bundibugyo strain, medical teams must rely exclusively on rigorous containment, quarantine procedures, and symptomatic care. This emergency capital injection will provide the liquidity necessary for localized authorities to establish secure isolation units, maintain continuous essential health operations, and manage the broader logistical challenges of a fast moving, highly infectious disease.